How can somatic and germline genetic testing help me?

Treatment selection

These tests have several important benefits. The first is treatment selection. Treatment selection is important because advanced prostate cancer is different for everyone. A treatment that works well for one person might not help someone else. Getting all recommended tests helps your doctor decide an appropriate treatment plan for you.

For example, testing for changes in certain genes that help repair DNA helps your doctor decide whether a PARP inhibitor may be an option. For some people, a PARP inhibitor can be part of initial treatment when prostate cancer has spread and is still sensitive to hormone therapy. A PARP inhibitor may also be an option if your prostate cancer is no longer responding to hormone therapy.

Somatic testing also can show whether your tumor has changes called microsatellite instability (MSI-H), mismatch repair deficiency (dMMR), or high tumor mutational burden (TMB-H). In this case, immunotherapy may work well.

If your prostate cancer has spread and is still responding to hormone therapy, an FDA-authorized test for PTEN deficiency can help your doctor decide whether capivasertib with abiraterone and prednisone is an appropriate option. You can ask about this even if you’ve already started hormone therapy.

Only some of the important gene changes in prostate cancer are found through somatic testing. The rest are found through germline genetic testing. And PTEN testing needs to be ordered separately. Getting all recommended tests gives your doctor and you the most complete understanding of your treatment options.

Other benefits

These tests also can help you understand your prognosis, and whether you are eligible for clinical trials of new therapies. In addition, germline genetic testing can help you and your family find out if you are at increased risk for certain cancers. This can help everyone make informed choices to support the best possible health outcomes.

At what point during treatment should I be tested?

The tables below show somatic testing recommendations and germline genetic testing recommendations for different situations.

SituationIs Somatic Testing Recommended?
Advanced prostate cancer (has spread to other places in the body like the bones, lungs, or liver)Yes
Node-positive prostate cancer (has spread from the prostate gland to nearby lymph nodes, but not to other places in the body)Consider—talk with your doctor
Advanced prostate cancer that has progressed on treatmentConsider repeat testing*
A new treatment or test is availableConsider repeat testing
Localized prostate cancer (is confined to the prostate gland)Not usually
(you may wish to ask your doctor)

*Tumor genes can change (mutate) in response to treatment, which can affect the next treatment choice. This is why repeat somatic testing is considered if your cancer has progressed on a treatment.

SituationIs Germline Genetic Testing Recommended?
Advanced prostate cancerYes
Node-positive prostate cancerYes
Very high-risk or high-risk localized prostate cancerYes
At least one close blood relative* with: advanced, node-positive, or high-risk/very high-risk prostate cancer, female breast cancer (at or before age 50), male breast cancer (any age), pancreatic cancer, or ovarian cancerYes
At least two close blood relatives with prostate cancer or breast cancer on the same side of the familyYes
Prostate cancer and Ashkenazi Jewish ancestryYes
Diagnosed at age 55 or youngerConsider
(talk to your doctor)
Intermediate risk and intraductal/cribriform histologyConsider
(talk to your doctor)

*Close blood relatives include biological parents, grandparents, siblings, children, aunts, uncles, cousins, etc.

SituationIs PTEN Testing Recommended?
Metastatic prostate cancer that has not yet been treated with hormone therapy or is still responding to hormone therapy (mHSPC, also called mAPMN/S)Yes—ask about PTEN protein testing when metastatic prostate cancer is diagnosed.
Metastatic prostate cancer that is growing despite treatment to keep testosterone very low (mCRPC, also called mAPMR)Not routinely.
Prostate cancer that has spread to nearby lymph nodes but not to distant parts of the body (locally advanced)Not routinely.
Prostate cancer confined to the prostate glandNot routinely.
You are interested in joining a clinical trialTalk with your doctor. Some trials require PTEN testing to check whether you can join.

Should I wait for my results to start a new treatment?

It can take a few weeks to get your test results. Waiting for test results can feel stressful, but it helps you get the most effective and personalized care, which may improve your long-term outcomes. If you are concerned about waiting, ask your doctor if a short delay makes sense for your specific situation and to address any concerns about waiting.

Getting all recommended tests gives you and your doctor the most complete understanding of your treatment options.